{"count": 7, "results": [{"_id": "34640558", "pmid": 34640558, "pmcid": "PMC8509766", "title": "Anti-Obesity Medication Use in Children and Adolescents with Prader-Willi Syndrome: Case Review and Literature Search", "journal": "J Clin Med", "authors": ["Goldman VE", "Naguib MN", "Vidmar AP"], "date": "2021-09-30T00:00:00Z", "doi": "10.3390/jcm10194540", "meta_date_publication": "2021 Sep 30", "meta_volume": "10", "meta_issue": "19", "meta_pages": "", "score": 50249.383, "text_hl": "The most common reported side effect in the studies was increased @DISEASE_Disorders_of_Excessive_Somnolence @DISEASE_MESH:D006970 @@@somnolence@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ also showed improved @<m>DISEASE_Hyperphagia</m> @DISEASE_MESH:D006963 @@@hyperphagia@@@ without @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@. ", "citations": {"NLM": "Goldman VE, Naguib MN, Vidmar AP. Anti-Obesity Medication Use in Children and Adolescents with Prader-Willi Syndrome: Case Review and Literature Search J Clin Med. 2021 Sep 30;10(19):. PMID: 34640558", "BibTeX": "@article{34640558, title={Anti-Obesity Medication Use in Children and Adolescents with Prader-Willi Syndrome: Case Review and Literature Search}, author={Goldman VE and Naguib MN and Vidmar AP}, journal={J Clin Med}, volume={10}, number={19}}"}}, {"_id": "35651327", "pmid": 35651327, "pmcid": "PMC9252891", "title": "Metformin ameliorates olanzapine-induced disturbances in POMC neuron number, axonal projection, and hypothalamic leptin resistance", "journal": "BMB Rep", "authors": ["Kim J", "Lee N", "Suh SB", "Jang S", "Kim S", "Kim DG", "Park JK", "Lee KW", "Choi SY", "Lee CH"], "date": "2022-06-01T00:00:00Z", "doi": "10.5483/BMBRep.2022.55.6.026", "meta_date_publication": "2022 Jun", "meta_volume": "55", "meta_issue": "6", "meta_pages": "293-298", "score": 50246.64, "text_hl": "These findings suggest that @CHEMICAL_Olanzapine @CHEMICAL_MESH:D000077152 @@@olanzapine@@@-induced hypothalamic @GENE_POMC @GENE_18976 @@@POMC@@@ neuron abnormality and @GENE_LEP @GENE_16846 @@@leptin@@@ resistance, which can be ameliorated by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration, are the possible causes of subsequent @<m>DISEASE_Hyperphagia</m> @DISEASE_MESH:D006963 @@@hyperphagia@@@.", "citations": {"NLM": "Kim J, Lee N, Suh SB, Jang S, Kim S, Kim DG, Park JK, Lee KW, Choi SY, Lee CH. Metformin ameliorates olanzapine-induced disturbances in POMC neuron number, axonal projection, and hypothalamic leptin resistance BMB Rep. 2022 Jun;55(6):293-298. PMID: 35651327", "BibTeX": "@article{35651327, title={Metformin ameliorates olanzapine-induced disturbances in POMC neuron number, axonal projection, and hypothalamic leptin resistance}, author={Kim J and Lee N and Suh SB and Jang S and Kim S and Kim DG and Park JK and Lee KW and Choi SY and Lee CH}, journal={BMB Rep}, volume={55}, number={6}, pages={293-298}}"}}, {"_id": "33074581", "pmid": 33074581, "title": "Early metformin treatment improves pancreatic function and prevents metabolic dysfunction in early overfeeding male rats at adulthood.", "journal": "Exp Physiol", "authors": ["Previate C", "Malta A", "Miranda RA", "Martins IP", "Pavanello A", "de Oliveira JC", "Prates KV", "Alves VS", "Francisco FA", "Moreira VM", "Matiusso CCI", "de Moraes AMP", "Mathias PCF", "Franco CCDS"], "date": "2020-12-01T00:00:00Z", "doi": "10.1113/EP088846", "meta_date_publication": "2020 Dec", "meta_volume": "105", "meta_issue": "12", "meta_pages": "2051-2060", "score": 50245.707, "text_hl": "During the first 12 days of suckling, animals from SL and NL groups received @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, whereas the controls received saline injections. ", "citations": {"NLM": "Previate C, Malta A, Miranda RA, Martins IP, Pavanello A, de Oliveira JC, Prates KV, Alves VS, Francisco FA, Moreira VM, Matiusso CCI, de Moraes AMP, Mathias PCF, Franco CCDS. Early metformin treatment improves pancreatic function and prevents metabolic dysfunction in early overfeeding male rats at adulthood. Exp Physiol. 2020 Dec;105(12):2051-2060. PMID: 33074581", "BibTeX": "@article{33074581, title={Early metformin treatment improves pancreatic function and prevents metabolic dysfunction in early overfeeding male rats at adulthood.}, author={Previate C and Malta A and Miranda RA and Martins IP and Pavanello A and de Oliveira JC and Prates KV and Alves VS and Francisco FA and Moreira VM and Matiusso CCI and de Moraes AMP and Mathias PCF and Franco CCDS}, journal={Exp Physiol}, volume={105}, number={12}, pages={2051-2060}}"}}, {"_id": "35565916", "pmid": 35565916, "pmcid": "PMC9103725", "title": "Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment", "journal": "Nutrients", "authors": ["Erhardt É", "Molnár D"], "date": "2022-05-06T00:00:00Z", "doi": "10.3390/nu14091950", "meta_date_publication": "2022 May 6", "meta_volume": "14", "meta_issue": "9", "meta_pages": "", "score": 50241.773, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment improved food-related distress and @DISEASE_Anxiety @DISEASE_MESH:D001007 @@@anxiety@@@, evaluated by @<m>DISEASE_Hyperphagia</m> @DISEASE_MESH:D006963 @@@Hyperphagia@@@ Questionnaire; however, @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight reduction@@@ did not occur.. ", "citations": {"NLM": "Erhardt É, Molnár D. Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment Nutrients. 2022 May 6;14(9):. PMID: 35565916", "BibTeX": "@article{35565916, title={Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment}, author={Erhardt É and Molnár D}, journal={Nutrients}, volume={14}, number={9}}"}}, {"_id": "39924659", "pmid": 39924659, "title": "Exploring the therapeutic potential of chlorogenic acid in alleviating olanzapine-induced metabolic syndrome in rats: a key role of hypothalamic satiety proteins.", "journal": "Nutr Neurosci", "authors": ["Ebrahimian Z", "Razavi BM", "Mousavi Shaegh SA", "Hosseinzadeh H"], "date": "2025-02-09T00:00:00Z", "doi": "10.1080/1028415X.2025.2460385", "meta_date_publication": "2025 Feb 9", "meta_volume": "", "meta_issue": "", "meta_pages": "1-20", "score": 50240.98, "text_hl": "@CHEMICAL_Chlorogenic_Acid @CHEMICAL_MESH:D002726 @@@CGA@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ mitigated these effects, although @CHEMICAL_Olanzapine @CHEMICAL_MESH:D000077152 @@@Olz@@@-induced elevation of @GENE_ADIPOQ @GENE_246253 @@@adiponectin@@@ levels remained unaffected by either treatment. ", "citations": {"NLM": "Ebrahimian Z, Razavi BM, Mousavi Shaegh SA, Hosseinzadeh H. Exploring the therapeutic potential of chlorogenic acid in alleviating olanzapine-induced metabolic syndrome in rats: a key role of hypothalamic satiety proteins. Nutr Neurosci. 2025 Feb 9;():1-20. PMID: 39924659", "BibTeX": "@article{39924659, title={Exploring the therapeutic potential of chlorogenic acid in alleviating olanzapine-induced metabolic syndrome in rats: a key role of hypothalamic satiety proteins.}, author={Ebrahimian Z and Razavi BM and Mousavi Shaegh SA and Hosseinzadeh H}, journal={Nutr Neurosci}, pages={1-20}}"}}, {"_id": "23893676", "pmid": 23893676, "title": "Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study.", "journal": "J Pediatr Endocrinol Metab", "authors": ["Miller JL", "Linville TD", "Dykens EM"], "date": "2014-01-01T00:00:00Z", "doi": "10.1515/jpem-2013-0116", "meta_date_publication": "2014 Jan", "meta_volume": "27", "meta_issue": "1-2", "meta_pages": "23-9", "score": 50060.14, "text_hl": "We administered the @<m>DISEASE_Hyperphagia</m> @DISEASE_MESH:D006963 @@@Hyperphagia@@@ Questionnaire to parents of @SPECIES_9606 @@@patients@@@ before and after starting @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment. ", "citations": {"NLM": "Miller JL, Linville TD, Dykens EM. Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study. J Pediatr Endocrinol Metab. 2014 Jan;27(1-2):23-9. PMID: 23893676", "BibTeX": "@article{23893676, title={Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study.}, author={Miller JL and Linville TD and Dykens EM}, journal={J Pediatr Endocrinol Metab}, volume={27}, number={1-2}, pages={23-9}}"}}, {"_id": "16157982", "pmid": 16157982, "title": "Markedly improved glycemic control and enhanced insulin sensitivity in a patient with type 2 diabetes complicated by a suprasellar tumor treated with pioglitazone and metformin.", "journal": "Intern Med", "authors": ["Igaki N", "Tanaka M", "Goto T"], "date": "2005-08-01T00:00:00Z", "doi": "10.2169/internalmedicine.44.832", "meta_date_publication": "2005 Aug", "meta_volume": "44", "meta_issue": "8", "meta_pages": "832-7", "score": 50048.137, "text_hl": "Additionally, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment showed marked anorectic effects on the @<m>DISEASE_Hyperphagia</m> @DISEASE_MESH:D006963 @@@hyperphagia@@@. ", "citations": {"NLM": "Igaki N, Tanaka M, Goto T. Markedly improved glycemic control and enhanced insulin sensitivity in a patient with type 2 diabetes complicated by a suprasellar tumor treated with pioglitazone and metformin. Intern Med. 2005 Aug;44(8):832-7. PMID: 16157982", "BibTeX": "@article{16157982, title={Markedly improved glycemic control and enhanced insulin sensitivity in a patient with type 2 diabetes complicated by a suprasellar tumor treated with pioglitazone and metformin.}, author={Igaki N and Tanaka M and Goto T}, journal={Intern Med}, volume={44}, number={8}, pages={832-7}}"}}]}